strategic investment

ScottsMiracle-Gro Company's (NYSE: SMG) newly created cannabis-focused subsidiary, The Hawthorne Collective, is lending $150 million to RIV Capital (TSX: RIV) (OTC: CNPOF). The move follows the company's recent announcement that it has seen record third-quarter sales, which amounted to...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is poised to acquire a stake in PharmaCann for approximately $110.4 million. Transaction Details: Under the terms of the agreement, a wholly-owned subsidiary of the Toronto-headquartered company has bought an option to obtain a roughly 10.5% ownership...